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Introduction
’Health’ is a concept that is difficult to define. A
well-known definition is given by the World Health
Organization (WHO): health is a state of complete
physical, mental and social well-being, and not merely
the absence of disease or infirmity. Some authors, for
example Grfisbeck [1], have criticized this definition as
unrealistic and have proposed others that stress the
absence of undesirable affections, the so-called privative
definitions. A more complete discussion of the notion
’health’ is beyond the scope of this paper.
All writers agree that health is a very individual state, so
it seems inappropriate to define it by ’normal values’ in
clinical chemistry. However, because it is not generally
possible to specify normal value for individuals, some
form of limit for detecting gross deviations from ’health’
would be useful. Of course no limit should be taken as
absolute and it should not be called a ’normal’ value, but,
rather, a ’reference’ limit. When determining reference
limits it is important to ensure that the reference
population matches the patient population as closely as
possible in all respects other than disease. Special
attention must be paid to similar age and sex distribu-
tions, social backgrounds, diets etc. Of course the same
sampling and analysis methods must be used for both
populations. Since blood donors or laboratory staff
usually at least do not have the same age distribution as
hospitalized patients, large discrepancies may be found if
the former groups are used as reference samples. The
International Federation of Clinical Chemistry (IFCC)
has given a series of recommendations on the theory of
reference values [2]. Solberg has designed a computer
program package (REFVAL) to assist in the statistical
treatment of reference values.
It would be very helpful ifhospital patients could be their
own references, or rather their colleagues’ ones. This
might well be possible if we assume that most patients
have only a few distrubed chemical parameters and are
’healthy’ in terms of the others. Then, in the bulk of
analyses, most results will be ’normal’ and the distribu-
tion will be polluted by pathological results only to a
small extent. This paper describes an attempt to filter out
these pathological values.
It must be noted that the benefit ofbeing able to establish
normal ranges that are more or less universal is reduced
by this approach, because most patient populations will
not sufficiently match the one the reference limits are
determined for. Furthermore, there will be a slight
variation in reference intervals determined at different
times in the same hospital. The authors consider the gain
in usefulness ofreference intervals to be greater than these
disadvantages.
Materials and methods
Apparatus
Analyses were performed on two Technicon SMA-C
continuous-flow analysers that determine sodium, potas-
sium, chloride, urea, creatinine, uric acid, alkaline
phosphatase (AP), lactate dehydrogenase (LDH), aspar-
tate aminotransferase (ASAT), alanine aminotransferase
(ALAT), total bilirubin, direct bilirubin, calcium, inor-
ganic phosphate, total protein, albumen, cholesterol,
triglycerides, iron and gamma glutamyl transferase
simultaneously in serum. For every sample analysed by
an SMA-C all components are measured,, due to the
concept of multichannel analysis. In this study this was
essential because the majority of the measurements on
each component came from patients in whom most
components were not pathological.
One SMA-C was for hospital patients and the other for
general practitioners’ patients. For data acquisition a
Hewlett-Packard HP 1000 computer system was used.
The program used for the calculations was written by
Hemel in Pascal and was run on the University’s Control
Data Cyber 170/760 computer. The plots were made on
the University’s Versatec V80 electrostatic plotter.
Techniques
Several methods have been devised in the past using the
idea of deriving reference intervals from patient popu-
lations. Naus [3] has reviewed the following methods:
Hoffmann [4 and 5]: a graphical method using probabil-
ity paper.
Neumann [6]: an iterative modification of the Hoffmann
method.
Pryce [7]: mean and standard deviation based on the
mode and percentiles of the non-distorted side of the
one-sidedly polluted distribution.
Becktel [8]: a modification of the Pryce method.
Bhattacharya [9]: mean and standard deviation are
derived from the intercept and slope of a plot of
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In (f(x + h)/f(x)) against x, withf(x)" frequency in class
with midpoint x, and h: class width.
Naus did not cover a method devised by Martin 10 and
11], who proposed population dissection by fitting two
(or three) Gram-Charlier functions that represent a
reference distribution, and a (two) polluting pathological
one(s), to the observed distribution.
The method of choice should meet the following require-
ments"
(1) As the exact distribution of a variable is usually
unknown, the method should preferably be non-
parametric: most methods do not meet this require-
ment, they suppose a Gaussian distribution, if neces-
sary after transformation. Martin’s method does not
make any assumption about the shapes of the popu-
lations. However, it supposes that the polluting patho-
logical cases belong to the same one (or two) popu-
lation(s).
(2) All pathological results should be filtered out: all
methods try to do so. Martin’s method places them in
one (or two) separate distribution(s).
After an extensive study of the methods he reviewed,
Naus advised the use of an automated and newly
objective Bhattacharya method for known Gaussian
distributions, and developed a method postulating a
Pearson gamma distribution for distributions that are
known to be non-Gaussian. Although Martin’s method
has the advantage of not making any assumptions about
the shape of the distributions, reasonably good estimates
for eight (or even 12) parameters are required to reach
convergence of the iterative procedure. We expected this
to be difficult to achieve. A further disadvantage is the
fact that the pathological cases are thought to form a
limited number ofpopulations (one or two). As the choice
between a gamma distribution and a Gaussian one was
supposed to be usually simple, Naus’s techniques were
tested with data from the Central Clinical Chemical
Laboratory.
(1) Random fluctuations’ these affect the low-
frequency bars of the histogram more than the
high-frequency bars.
(2) Deviations from the wanted regression line
because of pathological scores.
(a)
--
Concentration
(b)
Variables that are approximately normally distributed
The technique used was Naus’s modification of the
Bhattacharaya method [3 and 9]. A plot of In (f(x + h)/
f(x)) against x (withf(x): frequency in class with midpoint
x, and h: class width), gives a virtually straight line for a
normal distribution, presented as a histogram (see
Appendix A). A sample from a normal distribution that is
partially (only in the tails) distorted by pathological cases
will show a straight part in the plot for the ’clean’ fraction
of the sample (figure 1). It is possible to estimate the
population mean and variance from the x-intercept and
the slope, respectively. The problem of isolating the
straight part from the zig-zagging ones remains, this is
generally done by intuition. Naus proposed weighting
factors to reduce the influence ofthe distorted parts on the
regression line. Initially, wanted influences of two kinds
are accounted for in the weighting:
Figure 1. An example ofa Gaussian distribution that is polluted in
the tails. Figure 1 (a) shows the observed histogram and I (b) shows
the Bhattacharya plot belonging to it.
Deviations ofboth kinds should have as little influence as
possible on the regression line. Naus derived the following
weighting factor formula:
x + h) +J{))
(1 + d(x)/d(av))
where f(x) frequency ofclass with midpoint x
h class width
d(x) deviation from regression line ofclass
with midpoint x
d(av) average deviation from regression line
0 and [3 unknown powers.
21j. B. Hemel et al. Reference limits in clinical chemistry
Empirically optimal results are found for o 2 and [3 0,
so the weightings become:
w() (/( + )+ J()).
The statistical interpretation of these weightings is that
the variance in the class frequencies is not equal for all
classes and is balanced by the weightings.
By doing this, all short histogram bars (low frequencies)
have minimal influence on the regression line. This
method was tested on several artificially polluted Gaus-
sian curves by trying to retrieve the parameters of the
original curves. This gave excellent results. Subse-
quently, the author visually checked the results by
inspecting the Bhattacharya plot and regression line of
the smoothed histogram; the histogram is smoothed
before making a Bhattacharya plot for visual inspection
to get rid of the random fluctuations which mask the
straight part in the plot. Snoothing can be done following
the procedure described by Savitsky and Golay [13], and
corrected by Steinier et al. 14].
However, there are some drawbacks in this approach:
(a) The top part of the histogram should be ’clean’
(free from pathological results) because the weightings
only include the frequencies. The situation shown in
figure 2 is quite believable; ill patients form a distri-
bution that is almost uniform. The resulting super-
posed (and observed) Bhattacharya plot will not show
a straight part, although it might have a distortion that
is not conspicious, so that it could be overlooked
(figures 3 [a] and [b]). In practice, more than one
illness will disturb a ’healthy population’. It is difficult
to predict how the straight line will be distorted. Even
an exactly Gaussian distribution will not, in a practical
sample, show a perfectly straight line because of
random errors. So a seemingly straight line does not
guarantee that there really is a Gaussian distribution,
let alone that the observed slope and intercept give the
right parameters. For these reasons the method is not
adequate to test the hypothesis of dealing with a
Gaussian distribution, for which it is often used.
Statistically testing this hypothesis requires a
homogeneous distribution, so it is difficult to do. The
only way left is to base the usage of the method on prior
knowledge about the shape of the distribution, for
instance on calculations of coefficients of skewness and
kurtosis. Of course, these calculations cannot be made
for a mixed population such as the patient population
used here.
(b) Paradoxically, disturbed parts of the plot have
more influence on the regression line the more dis-
turbed they are, because by pollution with pathological
results their frequencies rise and consequently their
weightings also increase.
(c) In principle, the range of the histogram influences
the results because the tails ’pull with their weights’ at
the regression line. However, thanks to the small
weightings on the tailing parts, this effect.is small.
Therefore the part with higher frequencies is selected
rather than the undisturbed part.
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Concentration of variables
Figure 2. A fictional situation in which a Gaussian distribution of
’healthy’ people is distorted by adding another normal curve of
patients, with a large variance. This results in an observed curve
that is not readily recognized. The abscissa represents the
concentration (for example in serum) ofa relevant variable. Where
healthy population; patients; observed
distribution.
Some improvement could result from two modifications
of the technique:
(i) A threshold of a fraction of the mode, for example
one-tenth, to diminish the range effects.
(ii) An additional plot of residuals of unsmoothed
results after linear regression analysis, in order to
facilitate the detection of systematic deviations from
the Gaussian model. An example is seen in figure 1.
The Bhattacharya plot (figure 3[b]) appears to have a
straight part, but the plot of residuals shows clearly
that they are not randomly distributed about zero, so
calculated reference intervals will be wrong (figure
Sic]).
Variables that are definitely not normally distributed
These variables are supposed to follow a Pearson’s
gamma distribution. This is a two-parameter distribu-
tion: R for the number ofdegrees offreedom, and )v, which
is an extension factor. A chi-square distribution with v
degrees of freedom is a gamma distribution with R
0.5*v and lambda 0.5 (see Appendix C). Typical
shapes ofgamma distributions are illustrated in figure 4.
These curves are skewed but tend to become symmetrical
with many degrees of freedom.
The criteria for choosing the gamma curve as a model for
a variable’s distribution are"
(1) The distribution is known to be positively skewed
(long tail to the right).
(2) The shape of the Bhattacharya plot is bent. (It
should be straight if the distribution is normal.)J. B. Hemel et al. Reference limits in clinical chemistry
(a)
--+ Concentration
(b)
entration
Figure 3(a). A histogram of the situation described in figure 2.
Where--- thresholdfor calculations and plots.
(b) The Bhattacharya plot belonging to it, with the calculated
regression line.
(c) The plot ofresiduals belonging to the Bhattacharya plot. This
plot is drawn only for the reference interval estimated from the
regression line to aid interpretation.
(c)
-+ Concentration
R and )v are numerically estimated using a weighted linear
regression technique with the weightings as described
above (the procedure ofthe numerical estimation ofR and )v
is described in Appendix B). To establish upper (and
lower) boundaries the desired fractiles are calculated
from a chi-square distribution and transformed into a
gamma distribution interval (see Appendix C).
Comments
In Naus’s method the weightings for the linear regression
technique are derived from experiments with a Gaussian
distribution that is one-sidedly distorted by another
Gaussian distribution. One might question whether this
model is optimal for weighting gamma distributed
variables.
In the method described, the 97.5% fractile is chosen as
the upper boundary ofa one-sided reference interval. The
95 percentile might be more appropriate.
0.4
0.3
0.2
0.1 ,,_
R=I
1 /’",R 10
V ",,
10 12 14
-"" X
Figure 4. Some typical shapes ofgamma distribution curves, f(x)
is the probability density. Where )v 1, )v 2.
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Again, the range of the histogram used to estimate the
variable’s distribution is of some importance for the
results. So a threshold frequency of, say, one-tenth of the
modal frequency could bring some improvement.
Testing the quality of the derived reference intervals is, of
course, tedious. A way of checking is to compare them
with literature values, preferably from the same labora-
tory; of course this is not a thorough test because these
values are generally not based on a patient population. A
better quality control would be some form of in-process
checking: testing not the results, but, rather, the method.
The model used can bejudged visually by drawing a plot
that should be a straight line in the case of a perfect
gamma curve. The residuals can be plotted to determine
whether there are trends visible in the deviation from the
model. Details about these plots are given in Appendix B.
In figures 5, 6 and 7 the function for deriving a straight
line in the case of a gamma distribution is denoted by
F(k, R, x).
Discussion and results
Of course, the distributions of clinical chemical variables
are not exactly Gaussian or gamma. However, one may
hope that these distributions can be used as reasonably
good approximations. In many cases, intuition and prior
knowledge supports this idea. A major problem is finding
a good criterion to choose between the models and to test
the validity of the chosen model. Both methods should
perhaps be used and the best chosen on the basis of
interpretation of the plots of residuals. A major difficulty
is the necessary weighted interpretation of the plots.
Another criterion might be the estimated R parameter
(number ofdegrees offreedom) ofthe gamma approxima-
tion. IfR is greater than a certain number, for example
50, the distribution will be almost symmetrical and so a
Gaussian model might be appropriate. Although this
criterion may perform well in practice, it must be stressed
that, theoretically, it is not a guarantee for the right
choice. Fortunately, sometimes it is apparent that a
distribution is symmetrical, so that the Gaussian model
would be chosen, or positively skewed, that is, long tail to
the right, in which a gamma model would be more
appropriate.
Minor problems are the influence of the range of the
histograms and the coarseness in the estimation of the
interval that results. Reasons for these problems being
minor are the arbitrariness of the commonly used central
95% interval and the individuality of ’health’,
Many clinical chemical variables are strongly influenced
by such factors as age, sex, time and way of sampling. A
partitioning of the reference patient group according to
these parameters is necessary in order to avoid an
’averaged’ reference interval, which would, of course, be
worthless to a clinician. In some cases it may be necessary
to incorporate the varying precision ofanalytical methods
along the range ofpossible results in the weighting factors
to reach optimal reference intervals. For some determina-
tions, analytical precision is too small to resolve the model
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of the variable’s distribution. (In our case this applied to
the direct bilirubin determination.) Only variables used
in screenings are fit for this method of deriving reference
values, others are too strongly distorted by pathological
results.
Results are given in tables and 2. Choosing the b.est
model must be done by the reader. A suggestion is given
in the right-hand column (marked ’5’). Some typical plots
are given in figures 5, 6 and 7. Partitioning of the results
according to sex, age etc. was impossible for us; and this
means that some calculated reference values must be
doubtful (table 2). It is often difficult to conclude from the
calculations and plots whether the reference values found
are valid or not; see, for instance, the cholesterol reference
interval (table 2) and tile plots relating to it (figure 7).
The similarity between the reference intervals of (nearly)
Gaussian distributed variables if they are based on a
normal model and those based on a gamma model is
remarkable. One might suggest that a gamma model
provides for all cases, but in gamma distributions the
variance (=R/)2) is dependent on the mean (=R/)Q; this
is unlikely to always be the case with clinical chemical
variables, so the observed fact must be a coincidence.
Proof that a reference interval applies only to the patient
population it is derived from is demonstrated in table 3"
differences between intervals derived from hospital
patients and those derived from general practitioners’
patients occur, this is partly because of incomplete
filtering of the pathological cases and also because of
differences in the composition ofthe two populations. The
differences between the serum albumen and protein
intervals are the most marked.
Conclusions
It is possible to derive reasonable reference intervals for a
clinical chemical variable from a patient reference
population provided that:
(1) The variable has an approximately Gaussian or
gamma distribution.
(2) A choice can be made between these two models.
(3) The distribution is only partly distorted ’in the
tails’ by pathological observations.
(4) Many results are available (at least 1500).
(5) The precision of the determination is sufficiently
large to allow sufficiently small classes in the histogram
to ’resolve the model’.
(6) Results can be partitioned into groups which are
expected to have similar ’reference limits’ (sex, age
etc.).
(7) It is recognized that the values established are only
fit for a patient population that closely matches the
reference population.
(8) A small computer is available, preferably one with
plotting facilities.j. B. Hemel et al. Reference limits in clinical chemistry
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(a)
Figure 5. A series ofplots for potassium, for which a Gaussian
distribution fits well. These plots are based on a mixture of
hospital and general practitioner’s patients.
None ofthese plots is smoothed.
(a) Histogram observed (with threshold)
(b) Bhattacharya plot with regression line.
(c) Residuals from Bhattacharya plot, drawn only for the
estimated reference interval.
(d) Plot to check the gamma model and regression line. (See
Appendix B.)
(e) Residualsfrom plot (d) tofacilitate the detection ofsystematic
deviationsfrom the gamma model.
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Figure 6. Series of plots for ASAT, for which a gamma
distribution fits well. These plots are based on a mixture of
hospital and general practitioner’s patients.
None of these plots is smoothed.
(a) Histogram observed (with threshold).
(b) Bhattacharya plot with regression line.
(c) Residuals from Bhattacharya plot, drawn only for the
estimated reference interval.
(d) Plot to check the gamma model and regression line. (See
Appendix B.)
(e) Residualsfrom plot (d) tofacilitate the detection ofsystematic
deviationsfrom the gamma model.
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Figure 7. Series of plots for cholesterol, for which a Gaussian
distribution fits well. However, as the results should have been
partitioned, the calculated reference interval (table 2) is nonsense.
These plots are based on a mixture of hospital and general
practitioner’s patients.
None of these plots is smoothed.
(a) Histogram observed (with threshold).
(b) Bhattacharya plot with regression line.
(c) Residuals from Bhattacharya plot, drawn only for the
estimated reference interval.
(d) Plot to check the gamma model and regression line. (See
Appendix B.)
(e) Residualsfrom plot (d) tofacilitate the detection ofsystematic
deviations from the gamma model.
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Table 1. Results based on unpartitioned variables. These results are based on a mixture of hospital patients and general practitioner’s
patients. The variables were not partitioned according to sex, age, etc.
Reference Reference One-sided
interval if interval if reference
Variable N h Unity Gaussian R Gamma interval
Sodium 6695 mmol/1 134"6-143"6 3678 134"7-143"7
Potassium 6778 0.1 mmol/1 3-66-5-09 146 3"71-5"14
Chloride 3400 mmol/1 98"6-109"1 1457 98"6-109"3
Urea 3246 0"5 mmol/1 1"92-7"50 12 2"59-8"21
Creatinine 3424 10 mol/1 42-108 18 46-118
LDH 3433 10 U/1 127-277 30 140-287
ASAT (SGOT) 4018 2 U/1 8"2-26"6 15 10"2-28"6
ALAT (SGPT) 3839 2 U/1 2"8-26"8 7 6"5-31"4
Total bilirubin 4085 tmol/1 1"7-11"6 8 3" 1-13"
Calcium 6610 0"04 mmol/1 2" 178-2"624 440 2" 186-2"635
Phosphate 4347 0.1 mmol/1 0.67-1"49 27 0"73-1"57
Total protein 4087 2 g/1 59"3-77"2 218 59"7-77"9
Albumen 4141 2 g/1 35"3-50"6 110 35"6-51"7
<7"64
<lll
<274
<26"8
<28"7
<12"0
<1"49
N
N
N
G
G
G?
G
G
G
N
G
N?
N?
Table 2. Results based on variables that should be partitioned but were not.
Reference interval
Variable N h Unity ifGaussian R4
Reference interval One-sided
ifGamma reference interval
AP* 3464 10 U/1 28-130 11
Cholesterol* 9499 0"25 mmol/1 2"31-8" 13 13
Iron’++ 4888 1.5 tmol/1 0-30"3 3
41-142 <132
2"92-9"00 <8"39
3" 1-52"2 <46’0
* Partitioning according to age is required.
Partitioning according to sex is required.
++ Partitioning according to sampling time is required.
Table 3. Differences between reference intervals derivedfrom hospital patients and those derivedfrom general practitioner’s patients.
Reference interval
Variable for hospital patients
Reference interval6
Width for GP patients Width Unity Difference
Sodium 134.9-144"8 9"9 134"8-142" 7 7"9 mmol/1 22"5%
Potassium 3"61-5-02 1"31 3"72-5" 12 1"40 mmol/1 1"2%
Chloride 98" 1-109"0 10"9 99"0-109"3 10"3 mmol/l 6-2%
ASAT (SGOT) 10.2-30"3 20"1 10"3-27"3 17"1 U/1 16-3%
ALAT (SGPT) 5"6-31"9 26-3 7"6-29"7 22"1 U/1 16"6%
Total bilirubin 2.9-13"9 11"0 3.3-12"5 9" tmol/1 18"4%
Calcium 2" 156-2-650 0-494 2" 187-2"611 0-424 mmol/1 15"8%
Phosphate 0’70-1"63 0"93 0"74-1.54 0"80 mmol/1 15"3%
Total protein 56-8-78"3 21"5 60"3-76"8 16"4 g/l 28"5%
Albumen 31"9-52"6 20"7 36"8-49"6 12"9 g/1 51"4%
(1) The reference intervals are specified to one-tenth of the class width.
(2) Number of reference patients.
(3) h: Class width.
(4) R: R-parameter of gamma-distribution, number of degrees of freedom.
(5) In this column a suggestion is given for the choice of the distribution model (N normal, G gamma, doubtful).
(6) The model suggested in table is used here.
(7) Calculated from interval before rounding off.
(8) Calculated as a percentage of the width of the overall reference interval from table 1.
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An alternative might be the method by Martin et al. [10
and 11], but this relies very heavily on ’magic computer
calculations’; Martin et M.’s method has not yet been
evaluated by the authors.
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Appendix A
Theoretical background to the Bhattacharya plot
Although for a histogram the theory of the Bhattacharya
plot is complicated (see Bhattacharya [9] or Naus [3]), a
basic explanation of its background is"
The probability density of a normal distribution is
defined by
x) ox/e
SO
+ Ix) fix+h) e-’/
o
and
logf(X + h.) -[(x [)2 + 2h(x- t) + h2 (x- )2]
Nx)
-h 2h- h2
02 202
So the variance can be calculated from the slope of
the regression line, and from the x-intercept (=
-y-intercept/slope) we find :
-h
slope
and
-y-intercept h
slope + -"
Because we are using histograms a (Sheppard) disconti-
nuity correction for o2 is necessary, so:
-h h2
slope 12
Appendix B
Estimating R and . fiom a distribution sample given as a
histogram
A gamma distribution is given by
Ax) x.- e-xx
with
F(R) =ofxn-’e-*dx=(R- 1) ofxn-2e-xdx=
(R- 1) F(R- 1)
(R> 0, X> 0, x > 0)
SO
jC{X "+" h) F(R) (x n t- h)R --1 e-X( + h)
and
h) log (R 1)log (1 + h/x) kh (1)
where h class width.
This formula applies only ifh is infinitely small. Ifnot, the
following approximation could be used"
logf(X + h) (R- 1)log (1 + h/x) ,h
+ hl-- -x[(Rl))
(R- 1)xa(R -2)] (2)
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This formula is derived as the first three terms ofa Taylor
series using some approximations. It is useless to
calculate more terms from the series because of the other
approximations that are necessary to get a formula that is
relatively easy to work with.
(1) and (2) can be represented by:
(1) Y =AX+B (3)
(2) Y A’X + B’ + G(),R,X)
or: Y- G(k,R,X) A’X + B’ (4)
f(x + h) with Y log J(x)
where x log (1 + h/x), etc.
Ifusing equation (3) a first estimation ofR and ) is made
from A and B, and these estimates can be substituted in
the left part of equation (4) to get better values from A’
and B’. By using equation (4) iteratively until con-
vergence is reached, approximations of R and t are
reached. These are too large and the estimates calculated
from equation are too small. The average estimate
’[3] -[- )[4] and R[3] + R[4]
2 2
are reasonably accurated (Naus [3]). If the sum of
equations (3) and (4) are divided by 2"
B+B’ y_ G(k,R,X) A+ A X + 2 2 2
or
A+A’ B+B’ F(k,R,X) X + 2 2
So a plot ofF(k,R,X) (with k and R’ the least estimates for
the parameters, based on (4)) against X, that is,
f(x) 24 x2 x3
against log (1 + h/x)
will give a straight line for a gamma distribution, with R
and k as estimates. Using the plot, R can be calculated
from the slope and lambda from the intercept of the
regression line. A plot of residuals can be drawn to detect
systematic deviations from the gamma model. Since the
regression is using weightings, the interpretation of the
results must also be weighted. To facilitate this, both
plots are made for the calculated reference interval only,
where no extreme low frequencies are present.
Appendix C
Finding gamma fractiles from a chi-square distribution
Chi-square distributions have the same relationship to
gamma distributions as standard normal distributions
have to normal ones. So from every gamma distribution a
chi-square version can be calculated.
Areas under the gamma distribution curve are given by
gamma (X,),R) ofket -e-XZdt.
F(R)
By substitution of p/(2)) we get:
f2.x 1-’(R) (1/2)RNR- le-1/2pdp.
And this is exactly the area under the curve of a
chi-square distribution with 2R degrees offreedom, from
0 to 2kx.
So gamma (x;),R) ?(2(2)x;2R).
By similar reasoning we find ?(2(x;v) gamma (x;1/2,
/2).
ZZ-1
(t) e dt
which is the formula for the area under the gamma-
distribution curve with R /2 and k l/2.
If R > 4, an acceptable approximation of the 0.025 and
0.975 fractiles is given by
(V’4R _+ 1.96) 2
which formula is based on a usual approximation of
chi-square fractiles [12].
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